Daewoong Pharmaceutical Co., Ltd (KRX:069620)
113,300
+100 (0.09%)
At close: Apr 2, 2025, 3:30 PM KST
Daewoong Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 24,735 | 121,739 | 42,240 | 24,506 | 12,753 | Upgrade
|
Depreciation & Amortization | 48,978 | 43,797 | 39,695 | 40,883 | 40,882 | Upgrade
|
Loss (Gain) From Sale of Assets | 465.97 | -30,198 | -246.4 | 1,029 | -7,530 | Upgrade
|
Asset Writedown & Restructuring Costs | 15,492 | 2,372 | 5,219 | 2,109 | 8,103 | Upgrade
|
Loss (Gain) From Sale of Investments | 24,951 | -130.67 | 4,112 | -8,308 | -2,622 | Upgrade
|
Loss (Gain) on Equity Investments | 23,153 | 1,443 | 374.54 | -257.52 | 355.37 | Upgrade
|
Stock-Based Compensation | 545.31 | 1,618 | 1,841 | 2,005 | 1,195 | Upgrade
|
Provision & Write-off of Bad Debts | 2,192 | 5,835 | 2,250 | 2,125 | 3,596 | Upgrade
|
Other Operating Activities | -6,226 | 10,254 | -8,852 | 5,813 | 20,263 | Upgrade
|
Change in Accounts Receivable | -22,597 | -478.7 | -23,193 | -20,692 | 44,176 | Upgrade
|
Change in Accounts Payable | -16,674 | 16,597 | 12,408 | -8,373 | 1,865 | Upgrade
|
Change in Other Net Operating Assets | -43,523 | -36,838 | 42,368 | -844.34 | -22,056 | Upgrade
|
Operating Cash Flow | 51,492 | 136,009 | 118,215 | 39,994 | 100,981 | Upgrade
|
Operating Cash Flow Growth | -62.14% | 15.05% | 195.58% | -60.39% | 75.31% | Upgrade
|
Capital Expenditures | -155,145 | -109,338 | -65,227 | -29,088 | -26,486 | Upgrade
|
Sale of Property, Plant & Equipment | 43.05 | 1,446 | 483.47 | 257.43 | 17,700 | Upgrade
|
Cash Acquisitions | - | -5,807 | - | - | - | Upgrade
|
Divestitures | - | 45.59 | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -73,858 | -46,289 | -46,826 | -45,633 | -30,781 | Upgrade
|
Investment in Securities | -35,557 | -8,791 | 6,983 | -13,220 | -87,584 | Upgrade
|
Other Investing Activities | -636.34 | 3,123 | 67.5 | - | -0 | Upgrade
|
Investing Cash Flow | -265,451 | -165,621 | -106,872 | -87,683 | -127,152 | Upgrade
|
Short-Term Debt Issued | 80,000 | 113,742 | 86,154 | 52,352 | 52,087 | Upgrade
|
Long-Term Debt Issued | 325,187 | 65,000 | 149,683 | 108,357 | 91,561 | Upgrade
|
Total Debt Issued | 405,187 | 178,742 | 235,837 | 160,709 | 143,647 | Upgrade
|
Short-Term Debt Repaid | -106,264 | -87,934 | -1,212 | -53,258 | -4,357 | Upgrade
|
Long-Term Debt Repaid | -92,263 | -94,201 | -201,593 | -91,675 | -91,702 | Upgrade
|
Total Debt Repaid | -198,527 | -182,136 | -202,805 | -144,933 | -96,059 | Upgrade
|
Net Debt Issued (Repaid) | 206,660 | -3,394 | 33,032 | 15,776 | 47,588 | Upgrade
|
Issuance of Common Stock | - | 49,890 | - | 40,249 | 29,987 | Upgrade
|
Dividends Paid | -7,741 | -7,278 | -8,066 | -6,458 | -6,193 | Upgrade
|
Other Financing Activities | 1,702 | -0 | -9,450 | 656.41 | -4,796 | Upgrade
|
Financing Cash Flow | 200,621 | 39,218 | 15,517 | 50,224 | 66,587 | Upgrade
|
Foreign Exchange Rate Adjustments | 4,782 | -1,052 | 184.47 | 1,073 | -211.65 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | -0 | - | - | - | Upgrade
|
Net Cash Flow | -8,556 | 8,555 | 27,044 | 3,608 | 40,205 | Upgrade
|
Free Cash Flow | -103,653 | 26,671 | 52,988 | 10,906 | 74,495 | Upgrade
|
Free Cash Flow Growth | - | -49.67% | 385.84% | -85.36% | 111.12% | Upgrade
|
Free Cash Flow Margin | -7.29% | 1.94% | 4.14% | 0.95% | 7.06% | Upgrade
|
Free Cash Flow Per Share | -9008.37 | 2334.47 | 4786.97 | 991.08 | 6986.64 | Upgrade
|
Cash Interest Paid | 23,084 | 16,604 | 11,480 | 9,839 | 10,667 | Upgrade
|
Cash Income Tax Paid | 38,901 | 8,391 | 9,050 | 5,500 | 2,906 | Upgrade
|
Levered Free Cash Flow | -174,677 | -18,388 | -44,864 | 44,982 | 50,247 | Upgrade
|
Unlevered Free Cash Flow | -170,311 | -9,886 | -39,610 | 51,387 | 56,878 | Upgrade
|
Change in Net Working Capital | 81,246 | -25,991 | 27,360 | -29,462 | -62,231 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.